Discovery and preclinical profile of teneligliptin (3-[(2S,4S)-4-[4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)piperazin-1-yl]pyrrolidin-2-ylcarbonyl]thiazolidine): A highly potent, selective, long-lasting and orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes
Yoshida, T., Akahoshi, F., Sakashita, H., Kitajima, H., Nakamura, M., Sonda, S., Takeuchi, M., Tanaka, Y., Ueda, N., Sekiguchi, S., Ishige, T., Shima, K., Nabeno, M., Abe, Y., Anabuki, J., Soejima, A., Yoshida, K., Takashina, Y., Ishii, S., Kiuchi, S., Fukuda, S., Tsutsumiuchi, R., Kosaka, K., Murozono, T., Nakamaru, Y., Utsumi, H., Masutomi, N., Kishida, H., Miyaguchi, I., Hayashi, Y.
Bioorg.Med.Chem.
